Yayın:
Clinical evaluation of different applications of misoprostol and aglepristone for induction of abortion in bitches

dc.contributor.authorAǧaoǧlu, Ali Reha
dc.contributor.authorAslan, Selim
dc.contributor.authorEmre, Birten
dc.contributor.authorKorkmaz, Ömer
dc.contributor.authorKocamüftüoǧlu, Mesih
dc.contributor.authorSchäfer-Somi, Sabine
dc.contributor.buuauthorÖzdemir Salcı, Emsal Sinem
dc.contributor.buuauthorSeyrek-İntaş, Kamil
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentKadın Hastalıkları ve Doğum Ana Bilim Dalı
dc.contributor.researcheridAAH-7292-2019
dc.contributor.scopusid55921595900
dc.contributor.scopusid6603409870
dc.date.accessioned2024-02-15T06:17:41Z
dc.date.available2024-02-15T06:17:41Z
dc.date.issued2014-01-16
dc.description.abstractThe aim of the present study was to compare the clinical and endocrinological effects of different applications of misoprostol (MIS) and aglepristone (AGL) for the induction of abortion in bitches. For this purpose, 28 healthy pregnant bitches from different breeds, ages, body weights (Body weigt, BWs, 10-40 kg), and between Days 25 to 35 of gestation were used. Bitches were randomly assigned to four groups. In group I (GI, n = 7), AGL (10 mg/kg BW, s.c. on 2 consecutive days); in group 2 (GII, n = 7), AGL (as in GI), intravaginal MIS (IVag, 200 mu g for bitches with <= 20 kg BW, 400 mu g for bitches with >20 kg BW, daily intravaginally until completion of abortion); in group 3 (GIII, n = 7), AGL (as in GI), ICVag (as in CID, per os MIS (400 mu g for bitches with <= 20 kg BW, 800 mu g for bitches with >20 kg BW, daily orally, until completion of abortion); in group 4 (GIV, n = 7), AGL (as in GI), per os MIS (as GIII) were used. Clinical, vaginal, and ultrasonographic examinations were performed daily until abortion was completed. For measurement of serum progesterone, blood samples were collected in all groups immediately after the first AGL administration and every other day until completion of abortion. No statistical differences were found between groups concerning the duration until completion of abortion after treatment (nonsignificant); however, in GIL one bitch completed abortion 2 days after the start of treatment. (C) 2014 Elsevier Inc. All rights reserved.
dc.identifier.citationSalcı, E. S. Ö. vd. (2014). "Clinical evaluation of different applications of misoprostol and aglepristone for induction of abortion in bitches". Theriogenology, 81(7), 947-951.
dc.identifier.doi10.1016/j.theriogenology.2014.01.017
dc.identifier.endpage951
dc.identifier.issn0093-691X
dc.identifier.issn1879-3231
dc.identifier.issue7
dc.identifier.pubmed24576713
dc.identifier.scopus2-s2.0-84896094243
dc.identifier.startpage947
dc.identifier.urihttps://doi.org/10.1016/j.theriogenology.2014.01.017
dc.identifier.urihttps://pdf.sciencedirectassets.com/271179/1-s2.0-S0093691X14X00051/1-s2.0-S0093691X14000508/main.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjECoaCXVzLWVhc3QtMSJIMEYCIQDBbryk2iaFwCLVN4CxUPjtw%2FgMX6VQV0XntTffot35PQIhAOSmvaXsFDzh4p5EDVHGwCD4f4Yrtyd3Mp39AeKSItQWKrwFCNP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQBRoMMDU5MDAzNTQ2ODY1IgwRP4NVwKBO2qSqHiQqkAUR8BG2RLEySclkcHRwTE7qnFua5iGS%2FFNp9bdGUo1G6sxCRcxbQ091e2gInKCWK1jFXndJdA4JpJ%2FtDGpdSZmQZVoFS9c%2Bq1pyUJKv5y5g3KrVb65fqAEaAyfl3XtwfScvF3V8DrfVmU6X3I%2B6CipMEC7UY9DD97JD8SaswwvOv0GxlBdPD4UdYduZUaK9I1Af9nBpTZqMz8LySpAjS0Na6IS7%2F%2FpwwaVCgIlsiJRoJdkQ3JOnHOIW0%2FataRrce%2F9WhwdyVNv8XJb6O4dlwDY7SBxw8zdqNOKNkQLMrj7lD1dxMWYQY4uap8QMx%2F9jCa9XAlwpD%2Bk9SWfrosfMdvZsDdc1pBG26Y%2BDFPASLPEYwCi7Jqwd4btcUsVLWoN%2Bb3jCAZQqJSYbjsqutwPJTz%2B6T%2Bl3iS1ptpHE5bBmoEyedSjUQ%2F%2FUN7aoPzvo19%2F1DZXy7oAZO5wY5RqvnGqiDdZ7m3RklyHZCTN7OUhfXsvT4h3PFourW7AOiux8R1IdXC3S2JOvxRzplOwnmQRI6zHqvvxpZKYnJ6Xea%2FZzbCirRSqhd%2BJBrod3cJLXqqDFd1ib5z4t141O4Fm3XBdTuAk2R0sDoDmN2k3Wo3uW30OP%2FHlFFz3MDzE5NkBz5PIb1on9SAgKpUcU%2BQO3WEkyv4O2V5kAB%2BYB1TnchkQeYVWrqGJSI2HVNjhHz8VcU0Vzrh4wF3LTurcN3RcO9r5ae3Z%2BsePax6jD%2FW95Oe%2FfsYyyG%2FjjEsmpL6nxPVtUbXBe2i3pjXsrXGJJX6vQJC%2F4FhnfFidYhKNs1oXEuuA15bSNPMGStNY9LtXWGKjNs%2Bs416RLxR65tZbcNDe1U3aBB%2FUWAr%2FAb68PAC1dMURblV2uYTCZhtimBjqwAZr4H4567oU3NkOECVYq9fW%2FjYkYGGnaXEAeT5O4T5PhbVcslqt7YTjTLlb5pfDI7cahhi%2FXUWn%2FTppUe1CWst7x1cu18caekPF0AthJxsFiU8eXl64O6jpYkOS%2FoyoewbeDisgJyrSbq8eoHirJ2AHoR6RLlFYefQkh%2BV%2B8xKVcM%2BSSGXYhyEAMEbjeIcMhTKHn7qxV9Xic%2F%2B1l%2BXSWA0cqJkBgm9iaQ6K7YfBvzEzV&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Date=20230811T102811Z&X-Amz-SignedHeaders=host&X-Amz-Expires=299&X-Amz-Credential=ASIAQ3PHCVTY3TNUD37F%2F20230811%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Signature=0f50c9c47b27072ee9ec98cc0c5cbc425cb09e18017d8de03b0c1f5be06e5311&hash=8b4a38fe7356a929cc3b271386aa0948114a5d3635985a70317b082734577b1d&host=68042c943591013ac2b2430a89b270f6af2c76d8dfd086a07176afe7c76c2c61&pii=S0093691X14000508&tid=spdf-02a25a74-f5d5-4eb5-8dd7-d967c165959c&sid=407fb04e8b61c7433d1b0855fed086216967gxrqb&type=client&tsoh=d3d3LnNjaWVuY2VkaXJlY3QuY29t&ua=0e1459045603020653565e&rr=7f4fca501b3b5493&cc=tr
dc.identifier.urihttps://hdl.handle.net/11452/39726
dc.identifier.volume81
dc.identifier.wos000333569800010
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier
dc.relation.collaborationYurt içi
dc.relation.collaborationYurt dışı
dc.relation.journalTheriogenology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAbortion
dc.subjectPregnancy termination
dc.subjectAglepristone
dc.subjectMisoprostol
dc.subjectDog
dc.subjectCanidae
dc.subjectCanis familiaris
dc.subjectAbortion
dc.subjectAglepristone
dc.subjectPregnancy termination
dc.subjectDog
dc.subjectMisoprostol
dc.subjectPregnancy termination
dc.subjectAlfaprostol
dc.subjectPharmacokinetic profiles
dc.subjectDogs
dc.subjectIntravaginal application
dc.subjectCabergoline
dc.subjectDopamine agonist
dc.subjectProgesterone
dc.subjectOral misoprostol
dc.subjectBeagle bitches
dc.subjectReproductive biology
dc.subjectVeterinary sciences
dc.subject.emtreeAbortion
dc.subject.emtreeAnimal
dc.subject.emtreeArticle
dc.subject.emtreeChemically induced disorder
dc.subject.emtreeDog
dc.subject.emtreeFemale
dc.subject.emtreePregnancy
dc.subject.emtreePregnancy termination
dc.subject.emtreeVeterinary abortion
dc.subject.emtreeAbortive agent
dc.subject.emtreeAglepristone
dc.subject.emtreeEstrane derivative
dc.subject.emtreeMisoprostol
dc.subject.meshAbortifacient agents, nonsteroidal
dc.subject.meshAbortion, veterinary
dc.subject.meshAnimals
dc.subject.meshDogs
dc.subject.meshEstrenes
dc.subject.meshFemale
dc.subject.meshMisoprostol
dc.subject.meshPregnancy
dc.subject.scopusPyometra; Dog; Deslorelin
dc.subject.wosReproductive biology
dc.subject.wosVeterinary sciences
dc.titleClinical evaluation of different applications of misoprostol and aglepristone for induction of abortion in bitches
dc.typeArticle
dc.wos.quartileQ1 (Veterinary Sciences)
dc.wos.quartileQ3 (Reproductive Biology)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Kadın Hastalıkları ve Doğum Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atScopus

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama